Display options
Cite
Ahmadpanah M, Sheikhbabaei M, Haghighi M, et al. Validity and test-retest reliability of the Persian version of the Montgomery-Asberg Depression Rating Scale. Neuropsychiatr Dis Treat. 2016;12:603-7doi: 10.2147/NDT.S103869.
Ahmadpanah, M., Sheikhbabaei, M., Haghighi, M., Roham, F., Jahangard, L., Akhondi, A., Sadeghi Bahmani, D., Bajoghli, H., Holsboer-Trachsler, E., & Brand, S. (2016). Validity and test-retest reliability of the Persian version of the Montgomery-Asberg Depression Rating Scale. Neuropsychiatric disease and treatment, 12603-7. https://doi.org/10.2147/NDT.S103869
Ahmadpanah, Mohammad, et al. "Validity and test-retest reliability of the Persian version of the Montgomery-Asberg Depression Rating Scale." Neuropsychiatric disease and treatment vol. 12 (2016): 603-7. doi: https://doi.org/10.2147/NDT.S103869
Ahmadpanah M, Sheikhbabaei M, Haghighi M, Roham F, Jahangard L, Akhondi A, Sadeghi Bahmani D, Bajoghli H, Holsboer-Trachsler E, Brand S. Validity and test-retest reliability of the Persian version of the Montgomery-Asberg Depression Rating Scale. Neuropsychiatr Dis Treat. 2016 Mar 07;12:603-7. doi: 10.2147/NDT.S103869. eCollection 2016. PMID: 27022265; PMCID: PMC4788359.
Copy Download .nbib Format: NLM
Share it on

Neuropsychiatr Dis Treat. 2016 Mar 07;12:603-7. doi: 10.2147/NDT.S103869. eCollection 2016.

Validity and test-retest reliability of the Persian version of the Montgomery-Asberg Depression Rating Scale.

Neuropsychiatric disease and treatment

Mohammad Ahmadpanah, Meisam Sheikhbabaei, Mohammad Haghighi, Fatemeh Roham, Leila Jahangard, Amineh Akhondi, Dena Sadeghi Bahmani, Hafez Bajoghli, Edith Holsboer-Trachsler, Serge Brand

Affiliations

  1. Behavioral Disorders and Substances Abuse Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
  2. Hamadan Educational Organization, Ministry of Education, Hamadan, Iran.
  3. Center for Affective, Stress, and Sleep Disorders, Psychiatric Clinics of the University of Basel, Basel, Switzerland.
  4. Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran.
  5. Center for Affective, Stress, and Sleep Disorders, Psychiatric Clinics of the University of Basel, Basel, Switzerland; Department of Sport, Exercise and Health Science, Sport Science Section, University of Basel, Basel, Switzerland.

PMID: 27022265 PMCID: PMC4788359 DOI: 10.2147/NDT.S103869

Abstract

BACKGROUND AND AIMS: The Montgomery-Asberg Depression Rating Scale (MADRS) is an expert's rating tool to assess the severity and symptoms of depression. The aim of the present two studies was to validate the Persian version of the MADRS and determine its test-retest reliability in patients diagnosed with major depressive disorders (MDD).

METHODS: In study 1, the translated MADRS and the Hamilton Depression Rating Scale (HDRS) were applied to 210 patients diagnosed with MDD and 100 healthy adults. In study 2, 200 patients diagnosed with MDD were assessed with the MADRS in face-to-face interviews. Thereafter, 100 patients were assessed 3-14 days later, again via face-to-face-interviews, while the other 100 patients were assessed 3-14 days later via a telephone interview.

RESULTS: Study 1: The MADRS and HDRS scores between patients with MDD and healthy controls differed significantly. Agreement between scoring of the MADRS and HDRS was high (r=0.95). Study 2: The intraclass correlation coefficient (test-retest reliability) was r=0.944 for the face-to-face interviews, and r=0.959 for the telephone interviews.

CONCLUSION: The present data suggest that the Persian MADRS has high validity and excellent test-retest reliability over a time interval of 3-14 days, irrespective of whether the second assessment was carried out face-to-face or via a telephone interview.

Keywords: Montgomery–Asberg Depression Rating Scale; major depressive disorders; reliability; validation

References

  1. Schizophr Res. 2015 May;164(1-3):256-62 - PubMed
  2. Psychiatry Res. 2011 Aug 15;188(3):446-52 - PubMed
  3. J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57 - PubMed
  4. Front Psychiatry. 2014 Mar 31;5:36 - PubMed
  5. Arch Iran Med. 2010 May;13(3):217-22 - PubMed
  6. Psychiatry Res. 2015 Aug 30;228(3):235-42 - PubMed
  7. J Psychiatr Res. 2015 Oct;69:158-65 - PubMed
  8. BMC Psychiatry. 2011 Jan 20;11:14 - PubMed
  9. Br J Psychiatry. 1979 Apr;134:382-9 - PubMed
  10. Clin Pract Epidemiol Ment Health. 2005 Sep 26;1:16 - PubMed
  11. Arch Iran Med. 2015 Feb;18(2):76-84 - PubMed
  12. Eur Neuropsychopharmacol. 2013 Sep;23(9):1051-6 - PubMed
  13. Lancet. 1997 May 17;349(9063):1436-42 - PubMed
  14. J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62 - PubMed

Publication Types